CN103656377B - 一种内外兼治慢性前列腺炎的中药药物 - Google Patents
一种内外兼治慢性前列腺炎的中药药物 Download PDFInfo
- Publication number
- CN103656377B CN103656377B CN201310634557.6A CN201310634557A CN103656377B CN 103656377 B CN103656377 B CN 103656377B CN 201310634557 A CN201310634557 A CN 201310634557A CN 103656377 B CN103656377 B CN 103656377B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- chinese medicine
- chronic prostatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 201000007094 prostatitis Diseases 0.000 title claims abstract description 21
- 208000013507 chronic prostatitis Diseases 0.000 title claims abstract description 18
- 210000000582 semen Anatomy 0.000 claims abstract description 23
- 229940079593 drug Drugs 0.000 claims abstract description 16
- 241000628997 Flos Species 0.000 claims abstract description 10
- 241000218176 Corydalis Species 0.000 claims abstract description 9
- 239000012567 medical material Substances 0.000 claims abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 21
- 239000008280 blood Substances 0.000 abstract description 19
- 208000011580 syndromic disease Diseases 0.000 abstract description 6
- 230000009545 invasion Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 12
- 208000004880 Polyuria Diseases 0.000 description 11
- 230000035619 diuresis Effects 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000011084 recovery Methods 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 210000004908 prostatic fluid Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- UICBHOXXGLYZJH-UHFFFAOYSA-N 5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium Chemical compound C1=CC=C2CC[N+]3=CC4=CC=CC=C4C=C3C2=C1 UICBHOXXGLYZJH-UHFFFAOYSA-N 0.000 description 1
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 240000001829 Catharanthus roseus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002207 flavanone derivatives Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- SPIUTQOUKAMGCX-UHFFFAOYSA-N flavoxate Chemical compound C1=CC=C2C(=O)C(C)=C(C=3C=CC=CC=3)OC2=C1C(=O)OCCN1CCCCC1 SPIUTQOUKAMGCX-UHFFFAOYSA-N 0.000 description 1
- 229960000855 flavoxate Drugs 0.000 description 1
- 238000012948 formulation analysis Methods 0.000 description 1
- 239000009519 fu-yuan Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 229960000443 hydrochloric acid Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310634557.6A CN103656377B (zh) | 2013-11-27 | 2013-11-27 | 一种内外兼治慢性前列腺炎的中药药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310634557.6A CN103656377B (zh) | 2013-11-27 | 2013-11-27 | 一种内外兼治慢性前列腺炎的中药药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103656377A CN103656377A (zh) | 2014-03-26 |
CN103656377B true CN103656377B (zh) | 2016-08-17 |
Family
ID=50295935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310634557.6A Expired - Fee Related CN103656377B (zh) | 2013-11-27 | 2013-11-27 | 一种内外兼治慢性前列腺炎的中药药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103656377B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104042957A (zh) * | 2014-06-25 | 2014-09-17 | 姜丽莎 | 一种治疗前列腺炎的中药组合物 |
CN104116952A (zh) * | 2014-07-16 | 2014-10-29 | 吴凤金 | 一种治疗慢性前列腺炎的药物组合物 |
CN104474358A (zh) * | 2014-11-14 | 2015-04-01 | 山西振东开元制药有限公司 | 一种治疗前列腺炎的药物及其制备方法 |
CN105148135A (zh) * | 2015-10-08 | 2015-12-16 | 温州医科大学附属第一医院 | 一种治疗慢性前列腺炎的中药制剂 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1478500A (zh) * | 2002-08-28 | 2004-03-03 | 张安学 | 治疗前列腺炎症的膏药 |
CN1970018A (zh) * | 2005-11-22 | 2007-05-30 | 王庆忠 | 一种治疗前列腺炎的处方及其制备方法 |
CN101474387A (zh) * | 2009-01-22 | 2009-07-08 | 陈新奎 | 治疗前列腺疾病尿频肌肉肿胀痛阳痿早泄等的中药制剂 |
CN102028828A (zh) * | 2007-02-26 | 2011-04-27 | 北京亚东生物制药有限公司 | 一种治疗前列腺增生、尿闭的药物组合物及检测方法 |
CN102327512A (zh) * | 2011-09-21 | 2012-01-25 | 史俊萍 | 一种治疗前列腺炎的中药配方 |
CN102961508A (zh) * | 2012-12-14 | 2013-03-13 | 山东宏济堂制药集团有限公司 | 一种用于治疗前列腺炎前列腺增生的中药组合物 |
-
2013
- 2013-11-27 CN CN201310634557.6A patent/CN103656377B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1478500A (zh) * | 2002-08-28 | 2004-03-03 | 张安学 | 治疗前列腺炎症的膏药 |
CN1970018A (zh) * | 2005-11-22 | 2007-05-30 | 王庆忠 | 一种治疗前列腺炎的处方及其制备方法 |
CN102028828A (zh) * | 2007-02-26 | 2011-04-27 | 北京亚东生物制药有限公司 | 一种治疗前列腺增生、尿闭的药物组合物及检测方法 |
CN101474387A (zh) * | 2009-01-22 | 2009-07-08 | 陈新奎 | 治疗前列腺疾病尿频肌肉肿胀痛阳痿早泄等的中药制剂 |
CN102327512A (zh) * | 2011-09-21 | 2012-01-25 | 史俊萍 | 一种治疗前列腺炎的中药配方 |
CN102961508A (zh) * | 2012-12-14 | 2013-03-13 | 山东宏济堂制药集团有限公司 | 一种用于治疗前列腺炎前列腺增生的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN103656377A (zh) | 2014-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103071128B (zh) | 一种治疗痛经的外用贴膏 | |
CN101428097B (zh) | 治疗银屑病的中药制剂及其制备方法 | |
CN102228603B (zh) | 一种治疗尿潴留的中药 | |
CN101496887A (zh) | 治疗急性热重痒重、湿重症型和慢性荨麻疹的药物 | |
CN101987114A (zh) | 中草药外洗液配方 | |
CN103028091B (zh) | 一种治疗肝胆湿热的中药组合物 | |
CN102058715B (zh) | 一种治疗慢性前列腺炎的中药制剂及其制备方法 | |
CN103656377B (zh) | 一种内外兼治慢性前列腺炎的中药药物 | |
CN102526677B (zh) | 治疗风寒感冒的中药足浴组合物 | |
CN104043022A (zh) | 一种治疗妇科炎症的中药组合物 | |
CN102988675A (zh) | 一种治疗慢性前列腺炎的中药组合物及其制备方法 | |
CN104258304A (zh) | 一种通经祛风活络消痛的药酒 | |
CN104547961B (zh) | 一种治疗胆结石的中药组合物 | |
CN104043067A (zh) | 治疗骨病的外用药酒配方 | |
CN103768358B (zh) | 一种治疗慢性前列腺炎的中药组合物 | |
CN106109674A (zh) | 一种用于过敏性皮炎的中药组合物 | |
CN104758726A (zh) | 一种治疗尿路感染的中药组合物 | |
CN103495122B (zh) | 一种治疗泌尿系结石的中药 | |
CN101658652A (zh) | 一种治疗慢性阑尾炎的中药制剂 | |
CN102114211B (zh) | 一种治疗肝炎的中草药 | |
CN104027430A (zh) | 一种治疗血瘀型子宫肌瘤的中药组合物 | |
CN103933408A (zh) | 一种治疗急性痛风性关节炎的中药汤剂 | |
CN104274555B (zh) | 一种治疗风湿病的中药组合物、软膏剂及其制备方法 | |
CN103356959B (zh) | 一种治疗乳腺小叶增生的药物组合物 | |
CN103566011A (zh) | 一种治疗血栓闭塞性脉管炎的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Xia Yu Inventor after: Wang Deping Inventor after: Ren Xiaoping Inventor after: Dang Jianmin Inventor after: Li Fenggang Inventor before: Xia Yu Inventor before: Yu Ping Inventor before: Zhang Zhen Inventor before: Dang Jianmin Inventor before: Li Fenggang |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160621 Address after: 734000 No. 67, West Ring Road, Zhangye, Gansu Applicant after: Xia Yu Applicant after: Wang Deping Applicant after: Ren Xiaoping Address before: 734000 No. 67, West Ring Road, Zhangye, Gansu Applicant before: Xia Yu Applicant before: Yu Ping Applicant before: Zhang Zhen |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160817 |
|
CF01 | Termination of patent right due to non-payment of annual fee |